BeOne Medicines
ONC
#698
Rank
S$45.47 B
Marketcap
S$395.95
Share price
-0.59%
Change (1 day)
31.47%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): S$0.72

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is S$0.83. In 2024 the company made an earnings per share (EPS) of S-$7.96.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.72-109.07%
2024S-$7.96
2022S-$24.7027.35%
2021S-$19.40-19.96%
2020S-$24.2420.81%
2019S-$20.0631.52%
2018S-$15.25417.57%
2017S-$2.95-37.16%
2016S-$4.69158.95%
2015S-$1.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.31-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.21-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA